Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1049-1056

  Gildea, L A ^a   Morris, R E ^a   Newman, S L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; FIBRONECTIN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; VERY LATE ACTIVATION ANTIGEN 5;

ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; FUNGUS GROWTH; HISTOPLASMA CAPSULATUM; HOST RESISTANCE; HUMAN; HUMAN CELL; INGESTION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; PARASITE; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0035863891     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1049     Document Type: Article

References (64)

1. Histoplasmosis: A granulomatous inflammatory response
2. Histoplasmosis and AIDS
3. Histoplasmosis and coccidioidomycosis in individuals with AIDS: A clinical review
4. Molecular and cellular determinants of immunity to Histoplasma capsulatum
5. Macrophages in host defense against Histoplasma capsulatum
6. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum
7. Early activation of splenic macrophages by tumor necrosis factor a is important in determining the outcome of experimental bistoplasmosis in mice. [Published erratum appears in 1992 Infect. Immun. 60:5324.]
8. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ
9. Modulation of immune responses in marine pulmonary histoplasmosis
10. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice
11. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms
12. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ
13. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsalatum
14. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant marine γ interferon
15. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-γ
16. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts
17. The dendritic cell system and its role in immunogenicity
18. New insights into the mobilization and phagocytic activity of dendritic cells
19. Migration and maturation of Langerhans cells in skin transplants and explants
20. Antigen uptake and presentation by dendritic leukocytes
21. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration
22. The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system
23. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
24. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1
25. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura
26. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: Implications for immune function studies
27. Mononuclear cells from human lung parenchyma support antigen-induced T lymphocyte proliferation
28. Role of the adherence-promoting receptors, CR3, LFA-I, and p150,95, in binding of Histoplasma capsulatum by human macrophages
29. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages: Cellular, cytoskeleton requirement for attachment and ingestion
30. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores
31. Digestion of Histoplasma capsulatum yeasts by human macrophages. [Published erratum appears in 1992 J. Immunol. 149:3127.]
32. Use of ferrocyanide-reduced osmium tetroxide in electron microscopy
33. Recognition of Histoplasma capsulatum yeast-cell antigens by human lymphocytes and human T-cell clones. [Published erratum appears in 1992 J. Leukocyte Biol. 52:133.]
34. Proliferating dendritic cell progenitors in human blood
35. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
36. Human dendritic cells phagocytose and process Borrelia burgdorferi
37. Activation of human dendritic cells following infection with Mycobacterium tuberculosis
38. Human dendritic cell (DC)-based anti-infective therapy: Engineering DCs to secrete functional IFN-γ and IL-12
39. Trypanosoma cruzi infects human dendritic cells and prevents their maturation: Inhibition of cytokines, HLA-DR, and costimulatory molecules
40. Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages
41. Adhesion molecules on human lung dendritic cells and their role for T-cell activation
42. Regulation of the fibronectin receptor affinity by divalent cations
43. γ interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state
44. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro
45. Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ
46. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen
47. Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells
48. Mechanisms involved in uptake of Bordetella bronchiseptica by mouse dendritic cells
49. Interaction of Listeria monocytogenes with mouse dendritic cells
50. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells
51. Vaccination against chlamydial genital tract infection aft immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae
52. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
53. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major
54. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells
55. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro
56. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity
57. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis
58. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection
59. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response
60. The distinctive features Of influenza virus infection of dendritic cells
61. + T cells
62. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices
63. Presentation of mycobacterial antigens by human dendritic cells: Lack of transfer from infected macrophages
64. Survival of Histoplasma capsulatum in experimental histoplasmosis in mice